Position in CGEM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,304,884
+$1,379,954 QoQ
Shares Held
346,232
-0.1% QoQ
Ownership
0.538%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 183 holders
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGEM Over Time
Shares Held
Position Value (USD)
Derivatives in CGEM
reported options exposure · as of Jun 30, 2026CallValue
$364,200
CallShares
20,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. CGEM ranks #153 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in CGEM
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,304,884 | 346,232 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $364,200 | 20,000 | Call | Sole | 2026-08-14 | |
| 2026-03-31 | $4,924,930 | 346,582 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $284,200 | 20,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $3,751,823 | 362,495 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,264,293 | 550,471 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,846,534 | 510,828 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $5,928,649 | 783,177 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $10,157,657 | 833,962 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,200,611 | 788,567 | Shares | Sole | 2024-11-14 | |
| 2023-12-31 | $2,377,999 | 233,366 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,169,511 | 239,725 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,034,425 | 189,073 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,501,777 | 244,553 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,260,537 | 214,269 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,915,397 | 149,407 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,123,988 | 321,684 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $110,092 | 10,515 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $4,672,667 | 207,030 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,016,770 | 233,661 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $16,827,846 | 403,836 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||